All posts by: Michael Zand

About Michael Zand

Blastic Plasmacytoid Dendritic Neoplasm Study Begins for CAR T-Cell Candidate – Rare Disease Report

Continue reading

2017-08-18 NEWS

Blastic Plasmacytoid Dendritic Neoplasm Study Begins for CAR T-Cell Candidate
Rare Disease Report
Cellectis announced today that the Phase 1 clinical study testing their CAR T-cell therapy, UCART123, to treat blastic plasmacytoid dendritic cell neoplasm (BPDCN) at the MD Anderson Cancer Center has begun, and the first patient was given the drug.
Cellectis Starts BPDCN Phase I Trial with Gene-Edited CART TherapyGenetic Engineering & Biotechnology News (blog)

all 2 news articles »

Continue reading

2017-08-18 NEWS

NBCNews.com

Scientists Find New Way to ‘Print’ Living Tissue
NBCNews.com
To avoid this, the Oxford team, led by 3D-bioprinting scientist Alexander Graham from Oxford Synthetic Biology (OxSyBio), contained their cells within nanolitre droplets that were wrapped in a lipid coating. These droplets could then be placed one
Scientists 3D-print ‘high-resolution’ living tissueRT
Oxford scientists develop new method to 3D print ‘high resolution’ living tissuesInternational Business Times UK

all 4 news articles »

Continue reading

2017-08-18 NEWS

NBCNews.com

Scientists Find New Way to ‘Print’ Living Tissue
NBCNews.com
To avoid this, the Oxford team, led by 3D-bioprinting scientist Alexander Graham from Oxford Synthetic Biology (OxSyBio), contained their cells within nanolitre droplets that were wrapped in a lipid coating. These droplets could then be placed one
Scientists 3D-print ‘high-resolution’ living tissueRT
Oxford scientists develop new method to 3D print ‘high resolution’ living tissuesInternational Business Times UK

all 4 news articles »

Continue reading

2017-08-18 NEWS

Monsanto, ToolGen enter Crispr licensing pact
World Grain
ST. LOUIS, MISSOURI, U.S. — Monsanto Co. and ToolGen, Inc., a Seoul, South Korea-based biotechnology company specializing in genome editing, have reached a global licensing agreement for the use of ToolGen’s Crispr technology platform to develop …

Continue reading

2017-08-18 NEWS

Deccan Chronicle

Vitamin C may encourage blood cancer stem cells to die
Science Daily
Vitamin C may “tell” faulty stem cells in the bone marrow to mature and die normally, instead of multiplying to cause blood cancers. This is the finding of a study led by researchers from Perlmutter Cancer Center at NYU Langone Health, and published
High dose injections of vitamin C could help to fight blood cancer and stop it from spreading, study claimsDaily Mail
Vitamin C could help to fight cancer, a study claimsExpress.co.uk
Vitamin C stops blood cancer in miceSBS
The Sun –PanARMENIAN.Net
all 12 news articles »